Parkinson’s disease is a neurodegenerative condition that is still largely misunderstood. While it is understood that Parkinson’s is a progressive disease that ultimately ends in a fatality, there is still much to learn about how and why the condition develops as it does.
One of the first questions patients have when being diagnosed with Parkinson’s is what their prognosis looks like. Unfortunately, this can be difficult to answer as the prognosis varies greatly from person to person. Learn how long most people diagnosed with Parkinson’s disease can expect to live and what factors affect this timeline.
Parkinson’s Life Expectancy
The average life expectancy of someone with Parkinson’s disease is about 16 years after their diagnosis. With that said, the patient’s age at diagnosis is a major factor that can skew this number.
Patients who receive a diagnosis at a much younger age can live with the disease well into their 60s and 70s. In fact, many Parkinson’s patients diagnosed in their 30s can live for another 30 or 40 years after diagnosis. This means that in most cases, people with Parkinson’s have a relatively normal life expectancy.
Parkinson’s disease causes tremors that become more severe as the disease progresses. When these tremors become extreme, especially in senior patients with limited mobility, they can lead to serious falls.
Many Parkinson’s patients also become bedridden in the later stages of the disease, which can lead to blood clots and pneumonia.
Extending Life Expectancy with Parkinson’s
It is important to note that there are many other factors that can impact life expectancy when diagnosed with Parkinson’s disease. Patients who follow an unhealthy lifestyle and partake in habits like drinking or smoking can negatively impact their prognosis in a severe way.
On the other hand, those who lead a healthy lifestyle by following a well-balanced diet and getting regular exercise can help make their prognosis more positive.
A major factor that can extend life expectancy is adequate treatment. Patients who adhere to their treatments and work with an expert medical team can help increase their life expectancy.
Regenerative medicine, also known as stem cell therapy, is another approach being explored for the management of Parkinson’s disease. Mesenchymal stem cell (MSC) is a type of adult stem cell that can be found in various tissues, including bone marrow, adipose tissue (fat), and umbilical cord tissue.
The potential benefits of using MSCs for Parkinson’s disease treatment include their ability to differentiate into different cell types, their immunomodulatory properties, and their potential to promote tissue repair and regeneration.
Clinical trials evaluating the safety and efficacy of MSC therapy for Parkinson’s disease have been conducted or are underway. Preliminary results from some studies have shown promising outcomes, including improvements in motor symptoms, reduced inflammation, and enhanced quality of life.
This post was written by a medical professional at Stemedix Inc. At Stemedix we provide access to Regenerative Medicine for hair, also Stem cell treatment for Parkinson’s. Regenerative medicine has the natural potential to help improve symptoms sometimes lost from the progression of many conditions.